Amophar SRL
1.8 FTEAmophar reported total assets of 401,301 € at the end of the 2025 financial year (annual accounts filed with the NBB on 09 Jul 2026), with 1.8 full-time equivalent.
The score of Amophar shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -56 % Headcount (avg FTE) -77 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Amophar's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −138,093 € | ||||
| Equity | −€1.02m | ||||
| Cash | 10,513 € | ||||
| EBITDA | −148,271 € | ||||
| Total assets | 401,301 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 09 Jul 2026
- Year ended 31 Dec 2024filed on 26 Jun 2025
- Year ended 31 Dec 2023filed on 19 Nov 2024
- Year ended 31 Dec 2022filed on 16 Oct 2023
- Year ended 31 Dec 2021filed on 06 Oct 2022
Amophar's financial analysis
- Solvency-253.6%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Amophar
Amophar's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0839.385.540
- VAT number
- BE0839385540
- Peppol
- Registered · 0208:0839385540 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 09 Sep 2011
- Registered office
- 2627 Schelle
- Size
- Micro · 1.8 FTE
- Latest accounts
- 2025 · filed on 09 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Amophar (SRL) has been based in Schelle since 2011, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net loss of 138,093 € and equity of −€1.02m; its revenue is not published. With 1.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -253.6%, below the median of its sector (46.0%).
Companies similar to Amophar
Companies in the same business, of comparable size and area, outside its group.
- Maimonides Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 142 €
- Cosmedic Wholesale of pharmaceutical and medical goods Boechout · balance sheet 331,807 €
- Vifor Fresenius Medical Care Renal Pharma België Wholesale of pharmaceutical and medical goods Antwerp · balance sheet 621,679 €
- Fysiomed Wholesale of pharmaceutical and medical goods Edegem · balance sheet 663,931 €
- Endoceutics Wholesale of pharmaceutical and medical goods Brussels · balance sheet €3.45m
- Launchpad Europe Wholesale of pharmaceutical and medical goods Oostkamp · balance sheet 120,635 €
- Biocon Biologics Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €1.09m
- Wimeq Wholesale of pharmaceutical and medical goods Heusden-Zolder · balance sheet 48,978 €
Frequently asked questions about Amophar
What is the revenue of Amophar?
Amophar files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Amophar?
In Belgium, the VAT number is the company number prefixed with BE: BE0839385540 for Amophar, if the company is VAT-registered. Its company number (CBE) is 0839.385.540.
Where is the registered office of Amophar?
According to the CBE register, the registered office of Amophar is in 2627 Schelle.
What is the equity of Amophar?
At the close of the 2025 financial year, the equity of Amophar amounts to -1,017,799 €, a solvency of -253.6% of total assets.
How many people work at Amophar?
1.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Amophar?
The register lists 6 active mandates at Amophar. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Amophar
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →